Skip to main content

Table 2 Serum biochemical parameters of rats in the control, HFD, HFD + β3-AGO and HFD + β3-ANT groups

From: The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

 

Control(n = 8)

HFD (n = 8)

HFD + β3-AGO(n = 8)

HFD + β3-ANT(n = 8)

ALT (U/L)

36.56 ± 2.17

62.84 ± 7.73*

46.09 ± 1.75

80.98 ± 5.63

AST (U/L)

145.61 ± 11.9

205.80 ± 3.71*

163.14 ± 5.3

232.06 ± 6.9

TG (mmol/L)

0.37 ± 0.05

0.71 ± 0.05*

0.49 ± 0.07

0.96 ± 0.10

TC (mmol/L)

1.46 ± 0.06

2.71 ± 0.29*

2.34 ± 0.20

3.17 ± 0.12

LDL-C (mmol/L)

0.37 ± 0.05

0.65 ± 0.078*

0.50 ± 0.03

0.80 ± 0.08

FFA (mmol/L)

0.63 ± 0.05

0.88 ± 0.068*

0.75 ± 0.04

1.03 ± 0.07

  1. ALT alanine aminotransferase, AST aspartate aminotransferase, TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, FFA free fatty acid. *P < 0.05 vs the control group. P < 0.05 vs the HFD group